ARCHIVES

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007